Meta-analysisNew
Tirzepatide for adults living with obesity
Cochrane Database of Systematic Reviews · 2025
Research news
Every week we scan PubMed and ClinicalTrials.gov for new work on 34 peptides – sorted by strength of evidence, with the source for every entry.
Latest update · 19 Oct 2026
Meta-analysisNew
Efficacy and safety of triple hormone receptor agonist retatrutide for the management of obesity: a systematic review and meta-analysis
Expert Review of Clinical Pharmacology · 2025
Systematic reviewNew
Human evidence for BPC-157 in orthopaedic and regenerative medicine: a systematic review of efficacy and safety
Acta Orthopaedica Belgica · 2026
Archive
- Peptide research update · 19 Oct 202616 papers · 2 trials · MOTS-c, Epitalon, Tirzepatide, Retatrutide, Semaglutide
- Peptide research update · 17 Oct 20266 papers · 0 trials · GHK-Cu, Tirzepatide, Retatrutide, Thymosin alpha-1
- Peptide research update · 12 Oct 20269 papers · 1 trials · Tirzepatide, Retatrutide, Teriparatide & abaloparatide, Thymosin alpha-1, BPC-157
Get the weekly update
New studies every week on Instagram, TikTok and YouTube.
Go deeper
All 34 peptides in one book
Every profile: what it is, the key studies, the evidence grade and where it stands in 2026.
Peptilex – The Peptide Encyclopedia
- 34 peptides – from semaglutide to BPC-157 – in one book
- An evidence grade (A–E) and the key studies for every peptide
- Where each one stands in 2026 – US, EU and Switzerland
Coming soonPeptilex – The Honest GLP-1 HandbookSemaglutide, tirzepatide and the new pills, explained for adults over 50.